loader image
Monday, October 6, 2025
75 F
McAllen
- Advertisement -

Bill Adams Resigns as Regional CEO for Knapp Medical Center & Harlingen Medical Center

Breaking NewsCommunity News
5410

Translate to Spanish or other 102 languages!

Bill Adams Photo Mega Doctor News
Bill Adams Photo Mega Doctor News

Mega Doctor News

- Advertisement -

WESLACO, TEXAS – Knapp Medical Center and Harlingen Medical Center announced today that Bill Adams has officially resigned from his post as Regional CEO for Knapp Medical Center & Harlingen Medical Center, effective October 20, 2015.

In his statement, Adams said that, “After a career of more than 32 years in hospital operations, he is ready for a change that will give me time to pursue other interests.” Adams also made note of the relationships he forged during his time at Knapp and Harlingen Medical Center, saying, “Everything positive that has occurred during my tenure as Regional CEO is attributed to the excellent teams with whom I have had the honor of working.”

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
DHR Bariatric and Metabolic Institute becomes an Aetna Institute of Quality® Bariatric Surgery Facility
Next article
Urgent Care Center at Renaissance Offers Fast Care for Patients in the RGV

More Articles

DHR Health Breast Cancer Symposium, Oct. 11th 

To support providers in the community, the DHR Health Continuing Medical Education Department will host the Breast Cancer Symposium on Saturday, October 11, at the Edinburg Conference Center at Renaissance, located at 118 Paseo del Prado.

STHS Children’s to Host Monster Jam Patient Meet & Greet, Oct. 9th

On Thursday, October 9, 2025, from 2:00 – 4:00 p.m., the pediatric patients at South Texas Health System Children’s will have the opportunity to experience monster truck magic without leaving the hospital grounds.

Why Lobular Breast Cancer Can be Difficult to Detect

Reports show that one in eight women will be diagnosed with breast cancer in their lifetime. 

DHR Health Introduces Advanced PSMA-PET Imaging with Illuccix® for Prostate Cancer Care

To support early and accurate detection, DHR Health now offers Illuccix (kit for the preparation of gallium Ga 68 gozetotide injection), a prostate-specific membrane antigen (PSMA) targeted positron emission tomography (PET) imaging tracer for the detection of prostate cancer.
- Advertisement -

We feature articles about leading professionals in the medical and healthcare industry in the South Texas area. We are your connection to the medical community!

Pick up a copy of our publication on more than 800 locations Valley-wide.

Contact Us

Office (956) 928-1255

Sales (956) 451-4585

info@tbbmega.com

sales@tbbmega.com

Subscribe

To be updated with all the latest news and special announcements.

Visits counter

Coming back soon...

This website debuted on 10/05/2013

© Mega Doctor News 2024

×